The eosinophilias encompass a broad range of nonhematologic(secondary or reactive)and hematologic(primary or clonal)disorders with potential for end-organ damage.Based on new clinical data and increased understanding of disease molecular genetics,the World Health Organization(WHO)and the international consensus classification(ICC)has provided updated criteria and classifications for eosino-philic disorders in 2022.This guideline represents an update of Chinese expert consensus on the diagnosis and treatment of eosinophilia published in 2017 and aim to provide Chinese hematologist with clear guid-ance on management for eosinophilic disorders.
维普
万方数据